[HTML][HTML] Infliximab therapy for intestinal, neurological, and vascular involvement in Behcet disease: efficacy, safety, and pharmacokinetics in a multicenter, prospective …
T Hibi, S Hirohata, H Kikuchi, U Tateishi, N Sato… - Medicine, 2016 - journals.lww.com
Behçet disease (BD) is a multisystem disease associated with a poor prognosis in cases of
gastrointestinal, neurological, or vascular involvement. We conducted a multicenter …
gastrointestinal, neurological, or vascular involvement. We conducted a multicenter …
[PDF][PDF] Intestinal Behçet's disease: a true inflammatory bowel disease or merely an intestinal complication of systemic vasculitis?
DH Kim, JH Cheon - Yonsei medical journal, 2016 - synapse.koreamed.org
Behçet's disease (BD) is a multi-systemic inflammatory disorder of an unknown etiology and
shows a chronic recurrent clinical course. When the disease involves the alimentary tract, it …
shows a chronic recurrent clinical course. When the disease involves the alimentary tract, it …
[HTML][HTML] Evidence-based diagnosis and clinical practice guidelines for intestinal Behçet's disease 2020 edited by Intractable Diseases, the Health and Labour …
K Watanabe, S Tanida, N Inoue, R Kunisaki… - Journal of …, 2020 - Springer
Behçet's disease (BD) is an intractable systemic inflammatory disease characterized by four
main symptoms: oral and genital ulcers and ocular and cutaneous involvement. The …
main symptoms: oral and genital ulcers and ocular and cutaneous involvement. The …
Gastrointestinal involvement in Behçet disease
I Hatemi, G Hatemi, AF Çelik - Rheumatic Disease Clinics, 2018 - rheumatic.theclinics.com
Behcet disease (BD) was first described by a Turkish dermatologist as a triplesymptom
complex that consists of oral aphthous ulcers, genital ulcers, and uveitis. It is now …
complex that consists of oral aphthous ulcers, genital ulcers, and uveitis. It is now …
[PDF][PDF] Behçet's syndrome: a critical digest of the 2013-2014 literature
G Hatemi, E Seyahi, I Fresko, R Talarico… - Clin Exp …, 2014 - researchgate.net
This review focuses on the recent research on the epidemiology, outcome measures,
immunopathogenesis, genetics, clinical manifestations and management of Behçet's …
immunopathogenesis, genetics, clinical manifestations and management of Behçet's …
[PDF][PDF] Outcome predictors for intestinal Behçet's disease
JJ Park, WH Kim, JH Cheon - Yonsei medical journal, 2013 - synapse.koreamed.org
Behçet's disease (BD) is a multisystem inflammatory disorder that presents as recurrent oral
and genital ulcers in conjunction with other dermatological and ocular manifestations. The …
and genital ulcers in conjunction with other dermatological and ocular manifestations. The …
Fecal calprotectin as a non‐invasive biomarker for intestinal involvement of Behçet's disease
DH Kim, Y Park, B Kim, SW Kim, SJ Park… - Journal of …, 2017 - Wiley Online Library
Abstract Background and Aim The diagnostic and prognostic values of fecal calprotectin
(FC) levels in patients with inflammatory bowel diseases have been proven. However, little …
(FC) levels in patients with inflammatory bowel diseases have been proven. However, little …
[HTML][HTML] Optimal diagnosis and disease activity monitoring of intestinal Behçet's disease
HJ Lee, JH Cheon - Intest Res, 2017 - synapse.koreamed.org
Intestinal Behçet's disease (BD), generally accepted as a type of inflammatory bowel
disease (IBD), could be diagnosed when patients with BD have objectively documented …
disease (IBD), could be diagnosed when patients with BD have objectively documented …
[HTML][HTML] Influence of blood pressure variability on early carotid atherosclerosis in hypertension with and without diabetes
Carotid intima-media thickness (IMT) has been one widely used index of early carotid
atherosclerosis. We speculated that the influence of blood pressure variability (BPV) on …
atherosclerosis. We speculated that the influence of blood pressure variability (BPV) on …
[PDF][PDF] Treatment and outcomes: medical and surgical treatment for intestinal Behçet's disease
T Hisamatsu, M Hayashida - Intestinal research, 2017 - synapse.koreamed.org
Although there is little clinical evidence for its efficacy, 5-aminosalicylic acid (5-ASA) is used
as an empirical therapy for intestinal BD (Table 1). Jung et al. 2 retrospectively investigated …
as an empirical therapy for intestinal BD (Table 1). Jung et al. 2 retrospectively investigated …